股东权益报酬率(%) RoE | |
沃特世公司 | 1417.6 |
Mettler- | 320.1 |
QuidelOr | 36.5 |
Molina H | 35.5 |
联合健康集团股份 | 26.0 |
Encompas | 25.7 |
哈门那公司 | 21.0 |
奎斯特诊疗公司 | 20.8 |
U.S. Phy | 20.6 |
Henry Sc | 17.8 |
美华国际医疗科技 | 17.7 |
Masimo C | 17.1 |
Laborato | 15.8 |
Elevance | 15.6 |
The Cign | 13.0 |
珀金埃尔默公司 | 12.1 |
美国丹纳赫公司 | 11.5 |
Centene | 8.1 |
Hyperfin | 0 |
American | 0 |
Nemaura | 0 |
Enzo Bio | 0 |
Fulgent | 0 |
德康医疗公司 | 0 |
Co-diagn | 0 |
Illumina | 0 |
Accelera | 0 |
Natera, | 0 |
Invitae | 0 |
Owens & | 0 |
OpGen, I | 0 |
现金与约当现金比率(%) | |
Vicariou | 91.1 |
Hyperfin | 88.7 |
Nexalin | 82.7 |
AVITA Me | 82.0 |
Accelera | 78.1 |
PROCEPT | 77.3 |
Sight Sc | 77.2 |
恩德拉生命科学公 | 76.9 |
Eargo, I | 74.5 |
Tenon Me | 73.0 |
Exagen I | 70.7 |
Natera, | 70.1 |
Nemaura | 69.9 |
Renalyti | 68.6 |
Castle B | 65.0 |
Molina H | 62.9 |
NeuroOne | 62.7 |
Guardant | 62.0 |
NeuroPac | 61.6 |
Perspect | 61.5 |
Alignmen | 61.1 |
Delcath | 60.3 |
Rapid Mi | 60.2 |
德康医疗公司 | 60.1 |
Bluejay | 59.0 |
燃石医学有限责任 | 58.1 |
Co-diagn | 58.0 |
Vivani M | 56.0 |
Telesis | 55.9 |
FIGS, In | 52.0 |
CareDx, | 50.2 |
营业毛利率(%) | |
Delcath | 107.6 |
恩德拉生命科学公 | 100.0 |
Encompas | 95.9 |
Nexalin | 82.6 |
Castle B | 81.4 |
AVITA Me | 80.9 |
IMAC Hol | 77.1 |
Co-diagn | 74.8 |
Sight Sc | 74.5 |
Vivos Th | 72.9 |
NeuroPac | 72.6 |
FIGS, In | 71.5 |
燃石医学有限责任 | 69.7 |
Illumina | 68.2 |
QuidelOr | 67.2 |
德康医疗公司 | 65.5 |
Fulgent | 64.6 |
CareDx, | 64.1 |
Guardant | 63.9 |
Masimo C | 63.3 |
Xtant Me | 61.1 |
Akoya Bi | 59.9 |
沃特世公司 | 58.2 |
Mettler- | 58.2 |
医美国际控股集团 | 57.9 |
美国丹纳赫公司 | 57.7 |
珀金埃尔默公司 | 57.1 |
Exagen I | 54.2 |
Sotera H | 52.8 |
Aziyo Bi | 52.3 |
ProSomnu | 51.5 |
营业利益率(%) | |
QuidelOr | 37.7 |
沃特世公司 | 29.4 |
Fulgent | 28.2 |
Mettler- | 25.7 |
Sotera H | 24.8 |
美华国际医疗科技 | 22.7 |
珀金埃尔默公司 | 22.7 |
美国丹纳赫公司 | 21.6 |
Masimo C | 20.6 |
奎斯特诊疗公司 | 17.6 |
Laborato | 16.0 |
U.S. Phy | 15.8 |
Encompas | 15.4 |
Illumina | 15.4 |
Pediatri | 11.9 |
American | 11.9 |
FIGS, In | 7.9 |
联合健康集团股份 | 7.7 |
Akumin I | 7.0 |
Henry Sc | 6.8 |
德康医疗公司 | 6.3 |
RadNet, | 5.8 |
Molina H | 5.4 |
帕特森公司 | 2.9 |
Centene | 2.8 |
Owens & | 2.3 |
Nortech | 1.0 |
Kewaunee | 0.7 |
HH&L Acq | 0 |
Intellig | 0 |
Vicariou | 0 |
纯益率 / 净利率(%) | |
QuidelOr | 27.0 |
沃特世公司 | 24.0 |
Mettler- | 19.7 |
Fulgent | 19.4 |
Masimo C | 18.0 |
美国丹纳赫公司 | 17.7 |
美华国际医疗科技 | 16.7 |
珀金埃尔默公司 | 15.8 |
奎斯特诊疗公司 | 13.5 |
U.S. Phy | 12.3 |
Laborato | 9.9 |
Encompas | 8.9 |
德康医疗公司 | 8.1 |
联合健康集团股份 | 6.0 |
FIGS, In | 5.2 |
Henry Sc | 5.2 |
The Cign | 4.2 |
Elevance | 4.1 |
哈门那公司 | 3.6 |
Pediatri | 3.6 |
Molina H | 3.4 |
RadNet, | 2.6 |
Centene | 1.4 |
Nortech | 1.1 |
帕特森公司 | 0.0 |
Vivani M | 0 |
Vicariou | 0 |
HH&L Acq | 0 |
Intellig | 0 |
Owens & | -0.2 |
Kewaunee | -0.9 |
分红率(%) | |
联合健康集团股份 | 6.4 |
Elevance | 5.12 |
The Cign | 4.48 |
哈门那公司 | 3.15 |
Laborato | 2.16 |
奎斯特诊疗公司 | 1.98 |
U.S. Phy | 1.64 |
帕特森公司 | 1.04 |
美国丹纳赫公司 | 1 |
Encompas | 0.86 |
珀金埃尔默公司 | 0.28 |
Psycheme | 0.21 |
Hyperfin | 0 |
Co-diagn | 0 |
德康医疗公司 | 0 |
Nemaura | 0 |
American | 0 |
CareDx, | 0 |
沃特世公司 | 0 |
Centene | 0 |
Mettler- | 0 |
Enzo Bio | 0 |
Fulgent | 0 |
Henry Sc | 0 |
Illumina | 0 |
Accelera | 0 |
Molina H | 0 |
Natera, | 0 |
Invitae | 0 |
Owens & | 0 |
OpGen, I | 0 |